» Articles » PMID: 21602988

What is the Difference Between Helicobacter Pylori-associated Dyspepsia and Functional Dyspepsia?

Overview
Date 2011 May 24
PMID 21602988
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Advances in basic and clinical research have revealed that Helicobacter pylori (H. pylori) infection plays an important role in the development of gastroduodenal dysmotility and hypersensitivity, as also in dyspepsia symptoms. In addition, recent studies have proposed an inflammation-immunological model for the pathogenesis of functional dyspepsia. Since H. pylori is the major microbe that provokes a gastroduodenal inflammatory response, it should not be overlooked when considering the pathophysiology of dyspepsia symptoms. In fact, population-based studies have demonstrated that H. pylori is detected more frequently in dyspepsia patients. However, although many clinical studies tried to reveal the association of H. pylori infection with gastric motility dysfunction or hypersensitivity, the results have been conflicting. On the other hand, many etiological features were revealed for the development of H. pylori-associated dyspepsia, such as abnormal ghrelin or leptic secretion, altered expression of muscle-specific microRNAs, and duodenal inflammatory cell infiltration. In addition, therapeutic strategy for H. pylori-associated dyspepsia would be different from H. pylori-negative functional dyspepsia. This review focuses the issue of whether H. pylori-associated dyspepsia should be considered as a different disease entity from functional dyspepsia.

Citing Articles

Diagnostic Testing Accuracy for Infection among Adult Patients with Dyspepsia in Cuba's Primary Care Setting.

Duquesne A, Falcon R, Galindo B, Feliciano O, Gutierrez O, Baldoquin W Microorganisms. 2023; 11(4).

PMID: 37110419 PMC: 10146794. DOI: 10.3390/microorganisms11040997.


Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after eradication.

Mori H, Suzuki H, Matsuzaki J, Kameyama K, Igarashi K, Masaoka T Ann Med. 2022; 54(1):170-180.

PMID: 35000515 PMC: 9891226. DOI: 10.1080/07853890.2021.2024875.


Uninvestigated dyspepsia and associated factors of patients with gastrointestinal disorders in Dessie Referral Hospital, Northeast Ethiopia.

Seid A, Tamir Z, Demsiss W BMC Gastroenterol. 2018; 18(1):13.

PMID: 29347978 PMC: 5774098. DOI: 10.1186/s12876-017-0723-5.


Histomorphological Spectrum of Duodenal Pathology in Functional Dyspepsia Patients.

Chaudhari A, Rane S, Jadhav M J Clin Diagn Res. 2017; 11(6):EC01-EC04.

PMID: 28764169 PMC: 5535362. DOI: 10.7860/JCDR/2017/25297.9985.


The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia.

Suzuki H J Neurogastroenterol Motil. 2017; 23(3):325-333.

PMID: 28672431 PMC: 5503281. DOI: 10.5056/jnm17018.


References
1.
Akamizu T, Iwakura H, Ariyasu H, Kangawa K . Ghrelin and functional dyspepsia. Int J Pept. 2010; 2010. PMC: 2915802. DOI: 10.1155/2010/548457. View

2.
Fukuhara S, Suzuki H, Masaoka T, Arakawa M, Hosoda H, Minegishi Y . Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers. Am J Physiol Gastrointest Liver Physiol. 2005; 289(1):G138-45. DOI: 10.1152/ajpgi.00298.2004. View

3.
Lankarani K, Moghadami M, Masoumpoor M, Geramizadeh B, Omrani G . Serum leptin level in patients with functional dyspepsia. Dig Liver Dis. 2004; 36(11):717-21. DOI: 10.1016/j.dld.2004.07.001. View

4.
Gwee K, Teng L, Wong R, Ho K, Sutedja D, Yeoh K . The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2009; 21(4):417-24. DOI: 10.1097/MEG.0b013e328317b89e. View

5.
Saito Y, Suzuki H, Tsugawa H, Suzuki S, Matsuzaki J, Hirata K . Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice. Gastroenterology. 2010; 140(1):189-98. DOI: 10.1053/j.gastro.2010.08.044. View